Electrocardiogram (ECG) Validation Study
Not yet recruiting
- Conditions
- Arrythmia
- Registration Number
- NCT06414447
- Lead Sponsor
- Huxley Medical, Inc.
- Brief Summary
Comparison of diagnostic Electrocardiogram (ECG) signals
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of the diagnostic Electrocardiogram (ECG) signal quality of the P, QRS and T wave deflections of the Sansa device to a reference standard Holter monitor 3 months
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie arrhythmia detection using SANSA ECG technology?
How does SANSA ECG compare to standard 12-lead ECG in detecting arrhythmias like AFib or VTach?
Are there specific biomarkers that correlate with ECG signal accuracy in arrhythmia diagnosis?
What adverse events are associated with wearable ECG devices in long-term arrhythmia monitoring?
How do Huxley Medical's ECG innovations compare to other companies' cardiac monitoring technologies?